Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |